Joenja (leniolisib) — United Healthcare
activated phosphoinositide 3-kinase delta (PI3Kẟ) syndrome (APDS)
Initial criteria
- Diagnosis of activated phosphoinositide 3-kinase delta syndrome (APDS)
- AND
- age ≥ 12 years
Reauthorization criteria
- Documentation of positive clinical response to Joenja therapy
Approval duration
12 months